Skip to main content
Erschienen in: Breast Cancer Research and Treatment 1/2007

01.09.2007 | EPIDEMILOGY

Margin status and the risk of local recurrence after breast-conserving treatment of lobular breast cancer

verfasst von: N. van den Broek, M. J. C. van der Sangen, L. V. van de Poll-Franse, M. W. P. M. van Beek, G. A. P. Nieuwenhuijzen, A. C. Voogd

Erschienen in: Breast Cancer Research and Treatment | Ausgabe 1/2007

Einloggen, um Zugang zu erhalten

Abstract

Background Invasive lobular breast carcinoma is known for its multicentricity and is associated with a higher incidence of incomplete excision after breast-conserving therapy. The aim of the study was to examine the influence of positive surgical margins on the local recurrence rate in patients diagnosed with invasive lobular cancer and treated with breast-conserving therapy. Methods All 416 women diagnosed with invasive lobular breast cancer and undergoing breast-conserving treatment between 1995 and 2002 were selected from the population-based Eindhoven Cancer Registry. Their medical charts were reviewed and detailed information was collected. Results The risk of margin involvement was 29% after the first operation and 17% when taking into account the final margin status of the patients undergoing re-excision. During follow-up, 18 patients developed a local recurrence. The 5 year actuarial risk of developing a local recurrence was 3.5% (95% confidence interval 2.5–4.5) and the 8 year risk was 6.4% (95% confidence interval 4.7–8.0). There was no influence of positive surgical margins on the risk of local recurrence, neither in the univariate analysis nor after adjustment for age, tumour size, nodal status and adjuvant systemic treatment. Conclusion Patients with invasive lobular cancer, treated with breast-conservation, have a low risk of local recurrence, despite their high risk of having a microscopically incomplete excision of the tumour.
Literatur
1.
Zurück zum Zitat The World Health Organization Histological Typing of Breast Tumors–Second Edition (1982) The World Organization. Am J Clin Pathol 78(6):806–816 The World Health Organization Histological Typing of Breast Tumors–Second Edition (1982) The World Organization. Am J Clin Pathol 78(6):806–816
2.
Zurück zum Zitat Wellings SR, Jensen HM, Marcum RG (1975) An atlas of subgross pathology of the human breast with special reference to possible precancerous lesions. J Natl Cancer Inst 55(2):231–273PubMed Wellings SR, Jensen HM, Marcum RG (1975) An atlas of subgross pathology of the human breast with special reference to possible precancerous lesions. J Natl Cancer Inst 55(2):231–273PubMed
3.
Zurück zum Zitat Fisher ER, Gregorio RM, Fisher B, Redmond C, Vellios F, Sommers SC (1975) The pathology of invasive breast cancer. A syllabus derived from findings of the National Surgical Adjuvant Breast Project (protocol no. 4). Cancer 36(1):1–85PubMedCrossRef Fisher ER, Gregorio RM, Fisher B, Redmond C, Vellios F, Sommers SC (1975) The pathology of invasive breast cancer. A syllabus derived from findings of the National Surgical Adjuvant Breast Project (protocol no. 4). Cancer 36(1):1–85PubMedCrossRef
4.
Zurück zum Zitat Martinez V, Azzopardi JG (1979) Invasive lobular carcinoma of the breast: incidence and variants. Histopathology. 3(6):467–488PubMedCrossRef Martinez V, Azzopardi JG (1979) Invasive lobular carcinoma of the breast: incidence and variants. Histopathology. 3(6):467–488PubMedCrossRef
5.
Zurück zum Zitat Verkooijen HM, Fioretta G, Vlastos G et al. (2003) Important increase of invasive lobular breast cancer incidence in Geneva, Switzerland. Int J Cancer 104(6):778–81 Verkooijen HM, Fioretta G, Vlastos G et al. (2003) Important increase of invasive lobular breast cancer incidence in Geneva, Switzerland. Int J Cancer 104(6):778–81
6.
Zurück zum Zitat Li CI, Anderson BO, Daling JR, Moe RE (2003) Trends in incidence rates of invasive lobular and ductal breast carcinoma. JAMA 289(11):1421–1424PubMedCrossRef Li CI, Anderson BO, Daling JR, Moe RE (2003) Trends in incidence rates of invasive lobular and ductal breast carcinoma. JAMA 289(11):1421–1424PubMedCrossRef
7.
Zurück zum Zitat Sastre-Garau X, Jouve M, Asselain B, et al. (1996) Infiltrating lobular carcinoma of the breast. Clinicopathologic analysis of 975 cases with reference to data on conservative therapy and metastatic patterns. Cancer. 77(1):113–120PubMedCrossRef Sastre-Garau X, Jouve M, Asselain B, et al. (1996) Infiltrating lobular carcinoma of the breast. Clinicopathologic analysis of 975 cases with reference to data on conservative therapy and metastatic patterns. Cancer. 77(1):113–120PubMedCrossRef
8.
Zurück zum Zitat Yeatman TJ, Cantor AB, Smith TJ et al. (1995) Tumor biology of infiltrating lobular carcinoma. Implications for management. Ann Surg 222(4):549–559; discussion. 559–561 Yeatman TJ, Cantor AB, Smith TJ et al. (1995) Tumor biology of infiltrating lobular carcinoma. Implications for management. Ann Surg 222(4):549–559; discussion. 559–561
9.
Zurück zum Zitat Silverstein MJ, Lewinsky BS, Waisman JR, Gierson ED, Colburn WJ, Senofsky GM et al. (1994) Infiltrating lobular carcinoma. Is it different from infiltrating duct carcinoma? Cancer. 73(6):1673–1677PubMedCrossRef Silverstein MJ, Lewinsky BS, Waisman JR, Gierson ED, Colburn WJ, Senofsky GM et al. (1994) Infiltrating lobular carcinoma. Is it different from infiltrating duct carcinoma? Cancer. 73(6):1673–1677PubMedCrossRef
10.
Zurück zum Zitat Moore MM, Borossa G, Imbrie JZ et al. (2000) Association of infiltrating lobular carcinoma with positive surgical margins after breast-conservation therapy. Ann Surg 231(6):877–882PubMedCrossRef Moore MM, Borossa G, Imbrie JZ et al. (2000) Association of infiltrating lobular carcinoma with positive surgical margins after breast-conservation therapy. Ann Surg 231(6):877–882PubMedCrossRef
11.
Zurück zum Zitat Peiro G, Bornstein BA, Connolly JL (2000) The influence of infiltrating lobular carcinoma on the outcome of patients treated with breast-conserving surgery and radiation therapy. Breast Cancer Res Treat 59(1):49–54PubMedCrossRef Peiro G, Bornstein BA, Connolly JL (2000) The influence of infiltrating lobular carcinoma on the outcome of patients treated with breast-conserving surgery and radiation therapy. Breast Cancer Res Treat 59(1):49–54PubMedCrossRef
12.
Zurück zum Zitat Chung MA, Cole B, Wanebo HJ, Bland KI, Chang HR (1997) Optimal surgical treatment of invasive lobular carcinoma of the breast. Ann Surg Oncol 4(7):545–550PubMedCrossRef Chung MA, Cole B, Wanebo HJ, Bland KI, Chang HR (1997) Optimal surgical treatment of invasive lobular carcinoma of the breast. Ann Surg Oncol 4(7):545–550PubMedCrossRef
13.
Zurück zum Zitat Singletary SE, Patel-Parekh L, Bland KI (2005) Treatment trends in early-stage invasive lobular carcinoma: a report from the National Cancer Data Base. Ann Surg 242(2):281–289PubMedCrossRef Singletary SE, Patel-Parekh L, Bland KI (2005) Treatment trends in early-stage invasive lobular carcinoma: a report from the National Cancer Data Base. Ann Surg 242(2):281–289PubMedCrossRef
14.
Zurück zum Zitat Holland PA, Shah A, Howell A, Baildam AD, Bundred NJ (1995) Lobular carcinoma of the breast can be managed by breast-conserving therapy. Br J Surg 82(10):1364–1366PubMedCrossRef Holland PA, Shah A, Howell A, Baildam AD, Bundred NJ (1995) Lobular carcinoma of the breast can be managed by breast-conserving therapy. Br J Surg 82(10):1364–1366PubMedCrossRef
15.
Zurück zum Zitat Bouvet M, Ollila DW, Hunt KK, Babiera GV et al. (1997) Role of conservation therapy for invasive lobular carcinoma of the breast. Ann Surg Oncol 4(8):650–654PubMedCrossRef Bouvet M, Ollila DW, Hunt KK, Babiera GV et al. (1997) Role of conservation therapy for invasive lobular carcinoma of the breast. Ann Surg Oncol 4(8):650–654PubMedCrossRef
16.
Zurück zum Zitat Kurtz JM, Jacquemier J, Torhorst J et al. (1989) Conservation therapy for breast cancers other than infiltrating ductal carcinoma. Cancer 63(8):1630–1635PubMedCrossRef Kurtz JM, Jacquemier J, Torhorst J et al. (1989) Conservation therapy for breast cancers other than infiltrating ductal carcinoma. Cancer 63(8):1630–1635PubMedCrossRef
17.
Zurück zum Zitat Schnitt SJ, Connolly JL, Recht A, Silver B, Harris JR (1989) Influence of infiltrating lobular histology on local tumor control in breast cancer patients treated with conservative surgery and radiotherapy. Cancer 64(2):448–454PubMedCrossRef Schnitt SJ, Connolly JL, Recht A, Silver B, Harris JR (1989) Influence of infiltrating lobular histology on local tumor control in breast cancer patients treated with conservative surgery and radiotherapy. Cancer 64(2):448–454PubMedCrossRef
18.
Zurück zum Zitat Poen JC, Tran L, Juillard G et al. (1992) Conservation therapy for invasive lobular carcinoma of the breast. Cancer 69(11):2789–2795PubMedCrossRef Poen JC, Tran L, Juillard G et al. (1992) Conservation therapy for invasive lobular carcinoma of the breast. Cancer 69(11):2789–2795PubMedCrossRef
19.
Zurück zum Zitat Salvadori B, Biganzoli E, Veronesi P, Saccozzi R, Rilke F (1997) Conservative surgery for infiltrating lobular breast carcinoma. Br J Surg 84(1):106–109PubMedCrossRef Salvadori B, Biganzoli E, Veronesi P, Saccozzi R, Rilke F (1997) Conservative surgery for infiltrating lobular breast carcinoma. Br J Surg 84(1):106–109PubMedCrossRef
20.
Zurück zum Zitat White JR, Gustafson GS, Wimbish K et al. (1994) Conservative surgery and radiation therapy for infiltrating lobular carcinoma of the breast. The role of preoperative mammograms in guiding treatment. Cancer 74(2):640–647PubMedCrossRef White JR, Gustafson GS, Wimbish K et al. (1994) Conservative surgery and radiation therapy for infiltrating lobular carcinoma of the breast. The role of preoperative mammograms in guiding treatment. Cancer 74(2):640–647PubMedCrossRef
21.
Zurück zum Zitat Mai KT, Yazdi HM, Isotalo PA (2000) Resection margin status in lumpectomy specimens of infiltrating lobular carcinoma. Breast Cancer Res Treat 60(1):29–33PubMedCrossRef Mai KT, Yazdi HM, Isotalo PA (2000) Resection margin status in lumpectomy specimens of infiltrating lobular carcinoma. Breast Cancer Res Treat 60(1):29–33PubMedCrossRef
22.
Zurück zum Zitat Morrow M, Keeney K, Scholtens D, Wei J, Steel J, Khan SA (2006) Selecting patients for breast-conserving therapy: the importance of lobular histology. Cancer 106(12):2563–2568PubMedCrossRef Morrow M, Keeney K, Scholtens D, Wei J, Steel J, Khan SA (2006) Selecting patients for breast-conserving therapy: the importance of lobular histology. Cancer 106(12):2563–2568PubMedCrossRef
23.
Zurück zum Zitat Newman LA, Kuerer HM (2005) Advances in breast conservation therapy. J Clin Oncol 23(8):1685–1697PubMedCrossRef Newman LA, Kuerer HM (2005) Advances in breast conservation therapy. J Clin Oncol 23(8):1685–1697PubMedCrossRef
24.
Zurück zum Zitat Voogd AC, Nielsen M, Peterse JL et al. (2001) Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: pooled results of two large European randomized trials. J Clin Oncol1.9(6):1688–1697 Voogd AC, Nielsen M, Peterse JL et al. (2001) Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: pooled results of two large European randomized trials. J Clin Oncol1.9(6):1688–1697
25.
Zurück zum Zitat Rutgers EJ, Nortier JW, Tuut MK et al. (2002) [Dutch Institute for Healthcare Improvement guideline, “Treatment of breast cancer”]. Ned Tijdschr Geneeskd 146(45):2144–2151PubMed Rutgers EJ, Nortier JW, Tuut MK et al. (2002) [Dutch Institute for Healthcare Improvement guideline, “Treatment of breast cancer”]. Ned Tijdschr Geneeskd 146(45):2144–2151PubMed
Metadaten
Titel
Margin status and the risk of local recurrence after breast-conserving treatment of lobular breast cancer
verfasst von
N. van den Broek
M. J. C. van der Sangen
L. V. van de Poll-Franse
M. W. P. M. van Beek
G. A. P. Nieuwenhuijzen
A. C. Voogd
Publikationsdatum
01.09.2007
Verlag
Springer US
Erschienen in
Breast Cancer Research and Treatment / Ausgabe 1/2007
Print ISSN: 0167-6806
Elektronische ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-006-9431-5

Weitere Artikel der Ausgabe 1/2007

Breast Cancer Research and Treatment 1/2007 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.